Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
GSK publishes Prospectus and Circular
We have published the Prospectus and Circular for the proposed demerger of our Consumer Healthcare business to form Haleon.
Latest information
2022 First quarter results announcement
We announced our Q1 2022 results for the period which ended 31 March 2022 on Wednesday 27 April.
Latest press releases
- GSK completes acquisition of Sierra Oncology
- GSK selects Target the Future grant recipient in innovation challenge supporting multiple myeloma community
- Japan’s Ministry of Health, Labour and Welfare accepts Shingrix regulatory submission to prevent shingles in at-risk adults aged 18 years and older
Sign up for announcements
Sign up to receive email notifications when we publish a stock exchange announcement.